Cure My Disease

Don't miss your cure!

 Log in / Sign up

Immunotherapy after Chemo-Radiation may boost lung cancer survival

NCT ID NCT03540420

Ongoing Disease control Sponsor: Norwegian University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding the immunotherapy drug atezolizumab after standard chemo-radiotherapy helps people with limited-stage small-cell lung cancer live longer. About 212 participants will receive either atezolizumab or no additional treatment after chemo-radiation. The goal is to see if the drug improves 2-year survival rates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SMALL CELL LUNG CANCER

Contacts and locations

Locations

  • Aalborg Universitetshospital

    Aalborg, Denmark

  • Akershus Universitetssykehus AHUS

    Oslo, Norway

  • Amphia Ziekenhuis

    Breda, Netherlands

  • Antoni van Leeuwenhoek Ziekenhuis

    Amsterdam, Netherlands

  • Antonius Ziekenhuis

    Utrecht, Netherlands

  • Cancer Clinic at St. Olavs Hospital

    Trondheim, Norway

  • Cantonal Hospital of St. Gallen

    Sankt Gallen, Switzerland

  • Drammen sykehus - Vestre Viken

    Drammen, Norway

  • Erasmus MC

    Rotterdam, Netherlands

  • Gävle hospital

    Gävle, Sweden

  • Haugesund hospital

    Haugesund, Norway

  • Haukeland Universitetssykehus

    Bergen, Norway

  • Hirslanden Klinik

    Zurich, Switzerland

  • Inselspital

    Bern, Switzerland

  • Isala Ziekenhuis

    Zwolle, Netherlands

  • Kantonsspital Graubünden

    Chur, Switzerland

  • Kantonsspital Olten - Solothurner Spitäler

    Olten, Switzerland

  • Kantonsspital Winterthur

    Winterthur, Switzerland

  • Karolinska University Hospital

    Stockholm, Sweden

  • Medische Centrum Twente

    Enschede, Netherlands

  • Molde Sjukehus

    Molde, Norway

  • National Cancer Institute

    Vilnius, Lithuania

  • Odense University Hospital

    Odense, Denmark

  • Oslo University Hospital Ullevål

    Oslo, Norway

  • Rigshospitalet

    Copenhagen, Denmark

  • Rijnstate Ziekenhuis

    Arnhem, Netherlands

  • Sahlgrenska Universitetssjukhus

    Gothenburg, Sweden

  • Skånes University Hospital

    Lund, Sweden

  • Spital STS AG

    Thun, Switzerland

  • Stavanger University Hospital

    Stavanger, Norway

  • Sykehuset Levanger

    Levanger, Norway

  • Sykehuset i Kristansund

    Kristiansund, Norway

  • Sørlandet Sykehus

    Kristiansand, Norway

  • Universitetssjukhuset Linköping

    Linköping, Sweden

  • Universitetssjukhuset Örebro

    Örebro, Sweden

  • Universitetssykehuset Nord-Norge

    Tromsø, Norway

  • University Hospital Inselspital

    Bern, Switzerland

  • Universitätsspital Basel

    Basel, Switzerland

  • Volda hospital

    Volda, Norway

  • Zuyderland Ziekenhuis

    Sittard, Netherlands

  • Ålesund Hospital

    Ålesund, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.